Dupilumab For Management of Bullous Pemphigoids
1. Dupilumab treatment for bullous pemphigoids resulted in improved clinical symptoms. 2. Patients with anti-BP180 antibody levels of at least 50RU/mL and female sex responded better to dupilumab treatment for bullous pemphigoids Evidence Rating Level: 2 (Good) Study Rundown: Bullous pemphigoid (BP) is an autoimmune disease resulting in erythema, tense blisters, and severe itching. Onset
Source: 2minutemedicine.com
